₹53
₹65.14
Coupons & Offers
No Return or Exchange
Fast Delivery
Highlights
composition with strength
Povidone-Lodine Ip 5% W/W(Available Lodine 0.5% W/W)
dosage form
Ointment
description
Effective antiseptic treatment, prevents skin infections, suitable for minor wounds and burns, provides broad-spectrum protection
product type
Antiseptic Liquid
unit
20 g
packaging type
Tube
how to use
For external use only. Apply the cream to the affected area after cleaning and drying it. Use it as directed by your doctor and check the label for instructions
pack of
1
weight
20 g
application area
Skin
item form
Gel
consume type
Topical
key features
Broad-spectrum antimicrobial protection, treats minor wounds and skin infections, water-soluble formulation for easy application
Information
customer care details
In case of any issue, contact us E-mail address: support@zeptonow.com
disclaimer
The contents and images displayed on this Platform are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a registered medical practitioner with any questions you may have regarding a medical condition or the use of any product. Do not disregard professional medical advice or delay seeking it because of something you have read on this Platform.We intend to support, not replace, the doctor-patient relationship. While we make every effort to ensure the information provided is accurate and up-to-date, we strongly recommend reviewing product labels, batch numbers, manufacturing and packaging details, as well as any warnings and usage instructions before using or consuming any product.
Seller Name
Geddit Convenience Private Limited
Seller Address
Geddit Convenience Private Limited, Unit 803, Lodha Supremus, Saki Vihar Road, Opp MTNL, Office, Powai, Mumbai, Maharashtra, India,400072 For Support ReachOut : support+geddit@zeptonow.com
Seller License No.
11521998000248
Manufacturer Name
Cipla Limited
Country of Origin
India
Shelf Life
24 months
Expires on or after
November 2025